Lantheus Holdings (LNTH) Free Cash Flow Growth (5y) (2019 - 2026)
Lantheus Holdings (LNTH) Free Cash Flow Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.51 Bn | 30.57 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 7.05 Bn | 6.55 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.50% |
| Dec 31, 2025 | 45.03% |
| Sep 30, 2025 | 83.24% |
| Jun 30, 2025 | 87.34% |
| Mar 31, 2025 | 72.24% |
| Dec 31, 2024 | 45.71% |
| Sep 30, 2024 | 40.84% |
| Jun 30, 2024 | 26.76% |
| Mar 31, 2024 | 330.00% |
| Dec 31, 2023 | 72.23% |
| Sep 30, 2023 | 36.48% |
| Jun 30, 2023 | -37.87% |
| Mar 31, 2023 | 106.69% |
| Dec 31, 2022 | 31.73% |
| Sep 30, 2022 | 52.37% |
| Jun 30, 2022 | 31.79% |
| Mar 31, 2022 | 62.46% |
| Dec 31, 2021 | -32.80% |
| Sep 30, 2021 | -19.52% |
| Jun 30, 2021 | 8.89% |